Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology

Aim To collect information on current practices of European pathologists for the handling and reporting of nephrectomy specimens with renal tumours. Methods and Results A questionnaire was circulated to the members of the European Network of Uropathology, which consists of 343 pathologists in 15 European countries. Replies were received from 48% of members. These replies indicated that nephrectomy specimens are most often received in formalin. Lymph nodes are found in less than 5% of nephrectomy specimens. All respondents give an objective measure of tumour size, most commonly in three diameters. The most common method to search for capsule penetration is to slice tissue outside the tumour perpendicularly into the tumour. The most common sampling algorithm from tumours greater than 2 cm is one section for every centimetre of maximum tumour diameter. Most respondents use the 2004 WHO renal tumour classification although only slightly over half consider small papillary tumours malignant if the diameter is greater than 5 mm. The Fuhrman grading system is widely used. Almost all use immunohistochemistry for histological typing in some cases, while only 7% always use it. The most utilised special stains are CK7 (95%), CD10 (93%), vimentin (86%), HMB45 (68%), c-kit (61%) and Hale's colloidal iron (52%). Only 18% use other ancillary techniques for diagnosis in difficult cases. Conclusions While most pathologists appear to follow published guidelines for reporting renal carcinoma, there is still a need for the development of consensus and further standardisation of practice for contentious areas of specimen handling and reporting.

[1]  B. Delahunt,et al.  Many facets of chromosome 3p cytogenetic findings in clear cell renal carcinoma: the need for agreement in assessment FISH analysis to avoid diagnostic errors. , 2011, Histology and histopathology.

[2]  B. Delahunt,et al.  Grading of Clear Cell Renal Cell Carcinoma Should be Based on Nucleolar Prominence , 2011, The American journal of surgical pathology.

[3]  S. Culine,et al.  Kidney Cancer Pathology in the New Context of Targeted Therapy , 2011, Pathobiology.

[4]  D. Y. Guo,et al.  Discrepancy between radiological and pathological size of renal masses , 2011, BMC urology.

[5]  A. Renshaw,et al.  Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. , 2010, Archives of pathology & laboratory medicine.

[6]  B. Delahunt,et al.  Type 2 and clear cell papillary renal cell carcinoma, and tubulocystic carcinoma: a unifying concept. , 2010, Anticancer research.

[7]  S. Fleming Renal cell carcinoma in acquired cystic kidney disease , 2010, Histopathology.

[8]  A. Chang,et al.  Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens: common, harmful, yet underappreciated. , 2009, Archives of pathology & laboratory medicine.

[9]  B. Delahunt,et al.  Uncommon and recently described renal carcinomas , 2009, Modern Pathology.

[10]  B. Delahunt Advances and controversies in grading and staging of renal cell carcinoma , 2009, Modern Pathology.

[11]  Lars Egevad,et al.  The European Network of Uropathology: a novel mechanism for communication between pathologists. , 2009, Analytical and quantitative cytology and histology.

[12]  J. Brooks,et al.  Recommendations for the reporting of surgically resected specimens of renal cell carcinoma: the Association of Directors of Anatomic and Surgical Pathology. , 2009, Human pathology.

[13]  F. Algaba Renal Adenomas: Pathological Differential Diagnosis with Malignant Tumors , 2008, Advances in urology.

[14]  S. Boorjian,et al.  The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. , 2008, European urology.

[15]  L. Egevad,et al.  Handling and reporting of radical prostatectomy specimens in Europe: a web‐based survey by the European Network of Uropathology (ENUP) , 2008, Histopathology.

[16]  A. Chang,et al.  Non-neoplastic Renal Diseases are Often Unrecognized in Adult Tumor Nephrectomy Specimens: A Review of 246 Cases , 2007, The American journal of surgical pathology.

[17]  B. Delahunt,et al.  Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype , 2007, Pathology.

[18]  B. Delahunt,et al.  The evolution of collagen expression in sarcomatoid renal cell carcinoma. , 2007, Human pathology.

[19]  B. Delahunt,et al.  Fuhrman Grading is not Appropriate for Chromophobe Renal Cell Carcinoma , 2007, The American journal of surgical pathology.

[20]  K. Madbouly,et al.  Microvascular tumor invasion: prognostic significance in low-stage renal cell carcinoma. , 2007, Urology.

[21]  J. Cheville,et al.  Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. , 2006, The Journal of urology.

[22]  M. Stifelman,et al.  Impact of discordant radiologic and pathologic tumor size on renal cancer staging. , 2006, Urology.

[23]  B. Delahunt,et al.  Nucleolar Grade But Not Fuhrman Grade is Applicable to Papillary Renal Cell Carcinoma , 2006, The American journal of surgical pathology.

[24]  S. Bonsib Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases , 2006, Modern Pathology.

[25]  F. Algaba Is tumor necrosis a predictor of survival in patients with renal cell carcinoma? , 2006, Nature Clinical Practice Urology.

[26]  S. Bonsib T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. , 2005, The Journal of urology.

[27]  F. Marshall The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas. , 2005, The Journal of urology.

[28]  D. Grignon,et al.  Handling and reporting of tumor-containing kidney specimens. , 2005, Clinics in laboratory medicine.

[29]  F. Algaba,et al.  Intraoperative frozen section diagnosis in urological oncology. , 2005, European urology.

[30]  S. Jung,et al.  Renal cell carcinoma in South Korea: a multicenter study. , 2004, Human pathology.

[31]  F. Algaba,et al.  Handling and pathology reporting of renal tumor specimens. , 2004, European urology.

[32]  J. Cheville,et al.  Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma , 2003, The American journal of surgical pathology.

[33]  H. Moch,et al.  Sarcomatoid Differentiation in Renal Cell Carcinoma: A Study of 101 Cases , 2001, The American journal of surgical pathology.

[34]  H. Moch,et al.  Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma , 2000, Cancer.

[35]  P. Cin,et al.  Precancerous Lesions in the Kidney , 2000, Scandinavian journal of urology and nephrology. Supplementum.

[36]  J. Eble Recommendations for examining and reporting tumor-bearing kidney specimens from adults. , 1998, Seminars in diagnostic pathology.

[37]  B. Delahunt,et al.  Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[38]  O. G. Dodge Histological Typing of Kidney Tumours , 1982, British Journal of Cancer.

[39]  B. Delahunt,et al.  Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses. , 2010, American journal of clinical pathology.

[40]  S. Bonsib Renal veins and venous extension in clear cell renal cell carcinoma , 2007, Modern Pathology.

[41]  A. Marx,et al.  World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs , 2004 .

[42]  Cdm Fletcher,et al.  World Health Organization Classification of Tumours , 2002 .